David P. Schenkein - 21 Jun 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Director
Signature: /s/ William Cook, as Attorney-in-fact for David Schenkein
Issuer symbol: AGIO
Transactions as of: 21 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 23 Jun 2023, 16:34:47 UTC
Previous filing: 16 Jun 2023
Next filing: 12 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+4,975	+4.2%	$0.000000	122,854	21 Jun 2023	Direct
holding	AGIO	Common stock						270,772	21 Jun 2023	See footnote	F1
holding	AGIO	Common stock						79,082	21 Jun 2023	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock unit	Options Exercise	$0	-4,975	-100%	$0.000000^*	0	21 Jun 2023	Common stock	4,975		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.
F2	Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.
F3	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F4	The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested.